Relay Therapeutics, Inc. (RLAY) › Operating IncomeRelay Therapeutics, Inc. (RLAY) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$84.05M2020: -$55.80M2021: -$364.70M2022: -$299.27M2023: -$373.00M2024: -$372.47M2025: -$302.74M-$302.74M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$302.74M+18.7%2024-$372.47M+0.1%2023-$373.00M-24.6%2022-$299.27M+17.9%2021-$364.70M-553.6%2020-$55.80M+33.6%2019-$84.05M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share